uPAR A modulator of VEGF-induced angiogenesis

被引:27
作者
Uhrin, Pavel [1 ]
Breuss, Johannes M. [1 ]
机构
[1] Med Univ Vienna, Inst Vasc Biol & Thrombosis Res, Ctr Physiol & Pharmacol, Vienna, Austria
关键词
blood vessels; angiogenesis; endothelial cell migration; VEGF; uPAR; integrin alpha 5 beta 1; UROKINASE PLASMINOGEN-ACTIVATOR; ENDOTHELIAL-CELLS; BINDING-SITE; RECEPTOR; INTEGRIN; GROWTH; IDENTIFICATION; MONOCYTES; MIGRATION; SURFACE;
D O I
10.4161/cam.22124
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Vascular endothelial growth factor (VEGF)-initiated angiogenesis requires both coordinated proteolytic degradation of extracellular matrix provided by the urokinase plasminogen activator/urokinase receptor (uPA/uPAR) system and regulation of cell-migration provided by integrin-matrix interaction. Previously we have shown that stimulation of pericellular proteolysis induced by VEGF occurs via the VEGF receptor-2 leading to redistribution of uPAR to focal adhesions at the leading edge of endothelial cells. In our recent work published in Cardiovascular Research, we investigated the mechanisms underlying the uPAR-dependent modulation of VEGF-induced endothelial migration. By applying a micropatterning technique we described that VEGF stimulation results in complex formation between uPAR and alpha(5)beta(1)-integrin on the cell surface. The subsequent internalization of this complex, important for receptor redistribution, was demonstrated by flow-cytometry and immunohistochemistry. Targeting of the interaction site between uPAR and alpha(5)beta(1) impairs receptor internalization and leads to the inhibition of endothelial cell migration in vitro and in an angiogenesis model in vivo. This proof-of-principle that the interface of uPAR and alpha(5)beta(1)-integrin may represent a promising site to therapeutically target tumor angiogenesis raises hope for the development of an anti-angiogenic approach that is limited to only the mobilizing effect of VEGF to endothelial cells, and does not interfere with the inarguably positive effect of VEGF as survival factor.
引用
收藏
页码:23 / 26
页数:4
相关论文
共 19 条
[1]   A phase II, single-arm study of the anti-α5β1 integrin antibody volociximab as monotherapy in patients with platinum-resistant advanced epithelial ovarian or primary peritoneal cancer [J].
Bell-McGuinn, Katherine M. ;
Matthews, Carolyn M. ;
Ho, Steffan N. ;
Barve, Minal ;
Gilbert, Lucy ;
Penson, Richard T. ;
Lengyel, Ernst ;
Palaparthy, Rameshraja ;
Gilder, Kye ;
Vassos, Artemios ;
McAuliffe, William ;
Weymer, Sara ;
Barton, Jeremy ;
Schilder, Russell J. .
GYNECOLOGIC ONCOLOGY, 2011, 121 (02) :273-279
[2]   A function blocking anti-mouse integrin α5β1 antibody inhibits angiogenesis and impedes tumor growth in vivo [J].
Bhaskar, Vinay ;
Zhang, Dong ;
Fox, Melvin ;
Seto, Pui ;
Wong, Melanie H. L. ;
Wales, Pauline E. ;
Powers, David ;
Chao, Debra T. ;
DuBridge, Robert B. ;
Ramakrishnan, Vanitha .
JOURNAL OF TRANSLATIONAL MEDICINE, 2007, 5
[3]   UROKINASE PLASMINOGEN-ACTIVATOR RECEPTOR, BETA-2-INTEGRINS, AND SRC-KINASES WITHIN A SINGLE RECEPTOR COMPLEX OF HUMAN MONOCYTES [J].
BOHUSLAV, J ;
HOREJSI, V ;
HANSMANN, C ;
STOCKL, J ;
WEIDLE, UH ;
MAJDIC, O ;
BARTKE, I ;
KNAPP, W ;
STOCKINGER, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (04) :1381-1390
[4]   Angiogenesis in health and disease [J].
Carmeliet, P .
NATURE MEDICINE, 2003, 9 (06) :653-660
[5]   A region in urokinase plasminogen receptor domain III controlling a functional association with α5β1 integrin and tumor growth [J].
Chaurasia, Pratima ;
Aguirre-Ghiso, Julio A. ;
Liang, Olin D. ;
Gardsvoll, Henrik ;
Ploug, Michael ;
Ossowski, Liliana .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (21) :14852-14863
[6]   Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling [J].
Ghiso, JAA ;
Kovalski, K ;
Ossowski, L .
JOURNAL OF CELL BIOLOGY, 1999, 147 (01) :89-103
[7]   Targeting CD9 produces stimulus-independent antiangiogenic effects predominantly in activated endothelial cells during angiogenesis: A novel antiangiogenic therapy [J].
Kamisasanuki, Taro ;
Tokushige, Saori ;
Terasaki, Hiroto ;
Khai, Ngin Cin ;
Wang, Yuqing ;
Sakamoto, Taiji ;
Kosai, Ken-ichiro .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 413 (01) :128-135
[8]   An uncleavable uPAR mutant allows dissection of signaling pathways in uPA-dependent cell migration [J].
Mazzieri, R ;
D'Alessio, S ;
Kenmoe, RK ;
Ossowski, L ;
Blasi, F .
MOLECULAR BIOLOGY OF THE CELL, 2006, 17 (01) :367-378
[9]   IDENTIFICATION OF A NOVEL ANTI-INTEGRIN MONOCLONAL-ANTIBODY THAT RECOGNIZES A LIGAND-INDUCED BINDING-SITE EPITOPE ON THE BETA-1 SUBUNIT [J].
MOULD, AP ;
GARRATT, AN ;
ASKARI, JA ;
AKIYAMA, SK ;
HUMPHRIES, MJ .
FEBS LETTERS, 1995, 363 (1-2) :118-122
[10]   Vascular endothelial growth factor (VEGF) induces rapid prourokinase (pro-uPA) activation on the surface of endothelial cells [J].
Prager, GW ;
Breuss, JM ;
Steurer, S ;
Mihaly, J ;
Binder, BR .
BLOOD, 2004, 103 (03) :955-962